Damora Therapeutics (DMRA) Treasury Shares (2019 - 2026)
Damora Therapeutics' (DMRA) quarterly Treasury Shares came in at $957513.0 in Q1 2026, up 9061.05% YoY from $10452.0 in Q1 2025, and up 602109.43% on a QoQ basis from $159.0 in Q4 2025.
Damora Therapeutics (DMRA) Treasury Shares (2019 - 2026) Analysis & Trends
Damora Therapeutics (DMRA) has 5 years of Treasury Shares data on file, last reported at $957513.0 in Q1 2026.
- Quarterly Treasury Shares rose 9061.05% year-over-year to $957513.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $957513.0 (up 9061.05% YoY) and the FY2025 annual result came in at $7800.0, down 50.0% from the prior year.
- Treasury Shares climbed to $957513.0 in Q1 2026, from $159.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $957513.0 in Q1 2026 to a low of $159.0 in Q4 2025.
- A 3-year average of $280904.1 and a median of $10452.0 in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2025 — Treasury Shares sank 98.73% — and 2026, when it jumped 9061.05%.
- Tracing DMRA's Treasury Shares over 3 years: stood at $161.0 in 2024, then fell by 1.24% to $159.0 in 2025, then soared by 602109.43% to $957513.0 in 2026.
- The last three Treasury Shares figures came in at $957513.0 (Q1 2026), $159.0 (Q4 2025), and $7800.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Damora Therapeutics | 1.92 Bn | 1.38 Bn | - | 956,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 956,787.00 |
| Jun 30, 2026 | 956,787.00 |
| Mar 31, 2026 | 957,513.00 |
| Mar 31, 2026 | 957,513.00 |
| Dec 31, 2025 | 159.00 |
| Dec 31, 2025 | 159.00 |
| Sep 30, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Jun 30, 2025 | 10,452.00 |
| Jun 30, 2025 | 10,452.00 |
| Mar 31, 2025 | 10,452.00 |
| Mar 31, 2025 | 10,452.00 |
| Dec 31, 2024 | 161.00 |
| Dec 31, 2024 | 161.00 |
| Sep 30, 2024 | 16,600.00 |
| Sep 30, 2024 | 16,600.00 |
| Jun 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 820,000.00 |
| Mar 31, 2024 | 820,000.00 |